Clinical Trials in North Carolina

Showing 9021-9040 of 15,496 trials

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

NCT00441883

This study will evaluate the safety and efficacy of PF 03187207.

Primary Open Angle GlaucomaOcular HypertensionPigmentary Glaucoma+1 more

Bausch & Lomb Incorporated176 participantsStarted Mar 2007

Artesia, California, United States • Newport Beach, California, United States • Petaluma, California, United States +16 more locations

COMPLETEDPhase 246 miles

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308

The primary objective of this study is to evaluate the long term safety and tolerability of diacerein 1% ointment for 2 treatment cycles in subjects with EBS that previously participated in the CCP-020-301 or the CCP-020-101 studies.

Epidermolysis BullosaEpidermolysis Bullosa Simplex

Castle Creek Pharmaceuticals, LLC51 participantsStarted Dec 2017

Chicago, Illinois, United States • Chapel Hill, North Carolina, United States • San Antonio, Texas, United States

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Find Trials by Condition in North Carolina

PROMINENT-Eye Ancillary Study (Protocol AD)

Learning to Love Mealtime Together

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Dose Finding Study to Treat High Phosphate Levels in the Blood.

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

A Study of TRV130 for the Treatment of Pain After Bunionectomy

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

Randomized Evaluation of Default Access to Palliative Services

A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Pediatric Acute Gastrointestinal Bleeding Registry

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001